» Articles » PMID: 31578411

Acquisition of a Side Population Fraction Augments Malignant Phenotype in Ovarian Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2019 Oct 4
PMID 31578411
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Side population (SP) cells harbor malignant phenotypes in cancer. The aim of this study was to identify genes that modulate the proportion of ovarian cancer SP cells. Using a shRNA library targeting 15,000 genes, a functional genomics screen was performed to identify genes whose suppression increased the SP percentage. The biological effects caused by alteration of those identified genes were investigated in vitro and in vivo. We found that suppression of MSL3, ZNF691, VPS45, ITGB3BP, TLE2, and ZNF498 increased the proportion of SP cells. Newly generated SP cells exhibit greater capacity for sphere formation, single cell clonogenicity, and in vivo tumorigenicity. On the contrary, overexpression of MSL3, VPS45, ITGB3BP, TLE2, and ZNF498 decreased the proportion of SP cells, sphere formation capacity and single cell clonogenicity. In ovarian cancer cases, low expression of MSL3, ZNF691 and VPS45 was related to poor prognosis. Suppression of these six genes enhanced activity of the hedgehog pathway. Cyclopamine, a hedgehog pathway inhibitor, significantly decreased the number of SP cells and their sphere forming ability. Our results provide new information regarding molecular mechanisms favoring SP cells and suggest that Hedgehog signaling may provide a viable target for ovarian cancer.

Citing Articles

VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β-Catenin Signaling Pathway.

Zhi R, Li Q, Zhang H, Fan F Mol Carcinog. 2025; 64(4):744-755.

PMID: 39835603 PMC: 11890426. DOI: 10.1002/mc.23884.


The hematopoietic function, histological characteristics, and transcriptome profiling of Wanxi white geese ovary during nesting and late-laying stages.

Zhao C, Jin T, Yang K, Liu X, Ren M, She D Poult Sci. 2025; 104(2):104764.

PMID: 39764877 PMC: 11760318. DOI: 10.1016/j.psj.2025.104764.


LncRNA NR_045147 modulates osteogenic differentiation and migration in PDLSCs via ITGB3BP degradation and mitochondrial dysfunction.

Long L, Zhang C, He Z, Liu O, Yang H, Fan Z Stem Cells Transl Med. 2024; 14(2).

PMID: 39674578 PMC: 11878762. DOI: 10.1093/stcltm/szae088.


Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.

Vallejos P, Gonda A, Yu J, Sullivan B, Ostowari A, Kwong M Ann Surg Oncol. 2023; 30(6):3833-3844.

PMID: 36864326 PMC: 10175396. DOI: 10.1245/s10434-023-13219-7.


Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics.

Konishi I, Abiko K, Hayashi T, Yamanoi K, Murakami R, Yamaguchi K J Gynecol Oncol. 2022; 33(5):e83.

PMID: 36032027 PMC: 9428305. DOI: 10.3802/jgo.2022.33.e83.


References
1.
Agarwal R, Kaye S . Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003; 3(7):502-16. DOI: 10.1038/nrc1123. View

2.
Van Den Broeck A, Vankelecom H, Van Delm W, Gremeaux L, Wouters J, Allemeersch J . Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One. 2013; 8(9):e73968. PMC: 3775803. DOI: 10.1371/journal.pone.0073968. View

3.
Dai Y, Liu S, Zhang W, Yang Y, Hang P, Wang H . YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget. 2016; 8(3):4096-4109. PMC: 5354815. DOI: 10.18632/oncotarget.13686. View

4.
Chen Y, Bieber M, Teng N . Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer. Mol Carcinog. 2013; 53(8):625-34. DOI: 10.1002/mc.22015. View

5.
Bar E, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W . Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007; 25(10):2524-33. PMC: 2610257. DOI: 10.1634/stemcells.2007-0166. View